See more : Brookfield Infrastructure Partners L.P. (BIP) Income Statement Analysis – Financial Results
Complete financial analysis of Plant-Based Investment Corp. (CWWBF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Plant-Based Investment Corp., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Johnson & Johnson (JNJ.SW) Income Statement Analysis – Financial Results
- Axis Bank Limited (AXISBANK.NS) Income Statement Analysis – Financial Results
- Kutcho Copper Corp. (KC.V) Income Statement Analysis – Financial Results
- Digital Transformation Opportunities Corp. (DTOCW) Income Statement Analysis – Financial Results
- Vp plc (VP.L) Income Statement Analysis – Financial Results
Plant-Based Investment Corp. (CWWBF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.pbinvest.ca
About Plant-Based Investment Corp.
Plant-Based Investment Corp. is a principal investment firm. The firm seeks to invest in cannabis industry. It also invests in public cannabis companies. The firm employs fundamental analysis along with a combination of bottom-up and top-down stock picking approach to create its portfolios. Cannabis Growth Opportunity Corporation is based in Toronto, Canada.
| Metric | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|
| Revenue | -1.21K | -2.64M | 3.91M | 2.20M |
| Cost of Revenue | 0.00 | 132.50K | 327.46K | 245.00K |
| Gross Profit | -1.21K | -2.77M | 3.58M | 1.96M |
| Gross Profit Ratio | 100.00% | 105.02% | 91.62% | 88.88% |
| Research & Development | 0.00 | 4.16 | -0.55 | 1.20 |
| General & Administrative | 2.45M | 1.17M | 1.26M | -222.17K |
| Selling & Marketing | 276.77K | 214.77K | 405.23K | 222.17K |
| SG&A | 2.73M | 1.38M | 1.66M | 1.20 |
| Other Expenses | 0.00 | -8.24M | -5.66M | 282.08K |
| Operating Expenses | 2.98K | 8.24M | 5.66M | 2.08M |
| Cost & Expenses | 2.98K | 8.37M | 5.99M | 2.08M |
| Interest Income | 422.61K | 2.93M | 442.01K | 205.46K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | -5.20M | 8.37M | 5.99M | -167.82K |
| EBITDA | -5.20M | -2.64M | -2.08M | 2.37M |
| EBITDA Ratio | 430,980.53% | 417.00% | -53.30% | 4.70% |
| Operating Income | -4.19K | -11.01M | -2.08M | 2.54M |
| Operating Income Ratio | 347.22% | 417.00% | -53.30% | 115.43% |
| Total Other Income/Expenses | -7.79M | 24.04K | -67.89K | 3.48M |
| Income Before Tax | -7.79M | -10.99M | -2.15M | 2.65M |
| Income Before Tax Ratio | 645,295.13% | 416.08% | -55.04% | 120.13% |
| Income Tax Expense | -1.50M | -44.06K | 42.20K | 2.37M |
| Net Income | -6.29M | -10.95M | -2.19M | 2.65M |
| Net Income Ratio | 520,817.68% | 414.42% | -56.12% | 120.42% |
| EPS | 0.00 | -0.49 | -0.14 | 11.90M |
| EPS Diluted | 0.00 | -0.49 | -0.14 | 11.90M |
| Weighted Avg Shares Out | 21.97M | 22.16M | 15.66M | 0.22 |
| Weighted Avg Shares Out (Dil) | 21.97M | 22.16M | 15.66M | 0.22 |
PBIC Provides Update on Previously Announced Non-Brokered Private Placement
PBIC Announces Investment in Aion Therapeutic Inc.
Source: https://incomestatements.info
Category: Stock Reports